반응식
Cl[C:2]1[CH:7]=[CH:6][C:5]([B:8]2[O:12][C:11]([CH3:14])([CH3:13])[C:10]([CH3:16])([CH3:15])[O:9]2)=[CH:4][N:3]=1.CN.C[CH2:20][N:21](C(C)C)C(C)C>O1CCOCC1>[CH3:20][NH:21][C:2]1[CH:7]=[CH:6][C:5]([B:8]2[O:12][C:11]([CH3:14])([CH3:13])[C:10]([CH3:16])([CH3:15])[O:9]2)=[CH:4][N:3]=1참가 물질
5
실험 절차
A mixture of 2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (200 mg, 0.84 mmol), methanamine (277 mg, 8.4 mmol), and DIPEA (0.35 mL, 2.01 mmol) in dioxane (5 mL) was stirred at room temperature for 16 hours. It was then concentrated under reduced pressure, and the residue was treated in EtOAc. The insoluble solid was removed by filtration, and the organic solution was concentrated under reduced pressure to give the title compound.
후처리
- concentrationIt was then concentrated under reduced pressure
- additionthe residue was treated in EtOAc
- customThe insoluble solid was removed by filtration
- concentrationthe organic solution was concentrated under reduced pressure
출처 및 근거
- ORD 기록
- ord-9a28bae1fc6a40d8874fa0fae747a213
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09434726B2
연결된 노트
불러오는 중…